Lenalidomide Adherence in Older Adults



Status:Not yet recruiting
Conditions:Blood Cancer, Hematology, Hematology
Therapuetic Areas:Hematology, Oncology
Healthy:No
Age Range:65 - Any
Updated:2/17/2019
Start Date:February 28, 2019
End Date:November 30, 2019
Contact:Tanya M Wildes, M.D., MSCI
Email:twildes@wustl.edu
Phone:314-362-5817

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Lenalidomide Adherence in Older Adults: A Pilot Prospective Cohort Study of Oral Therapy for Multiple Myeloma

To describe patterns of adherence and pilot baseline measures to investigate factors
associated with lower adherence to lenalidomide in older adults with myeloma.


Inclusion Criteria:

- Age ≥65

- Receiving lenalidomide for treatment of multiple myeloma.

- Anticipated to receive ongoing care at Siteman Cancer Center and its satellite sites

- Able to read and understand English.

- Able to understand and willing to sign an IRB-approved written informed consent
document.

Exclusion Criteria:

- Estimated life expectancy <6 months.

- Anticipated duration of lenalidomide therapy <3 months.

- Residing in a nursing facility where their medications are administered to them OR
patient reports they do not self-administer their own medications.
We found this trial at
1
site
Washington University School of Medicine
660 S Euclid Ave
Saint Louis, Missouri 63110
(314) 362-5000
Principal Investigator: Tanya M Wildes, M.D., MSCI
Phone: 314-362-5817
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials